Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Epizyme Company Profile (NASDAQ:EPZM)

Consensus Ratings for Epizyme (NASDAQ:EPZM) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $36.52 (61.95% upside)

Analysts' Ratings History for Epizyme (NASDAQ:EPZM)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/7/2014Citigroup Inc.Reiterated RatingBuy$40.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
11/3/2014ZacksDowngradeOutperform -> Neutral$32.60ViewTweet This Rating  Share This Rating on StockTwits
10/3/2014ZacksUpgradeNeutral -> Outperform$31.10ViewTweet This Rating  Share This Rating on StockTwits
9/12/2014MizuhoInitiated CoverageBuy$35.00ViewTweet This Rating  Share This Rating on StockTwits
8/13/2014HC WainrightBoost Price TargetBuy$40.00 -> $45.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2014ZacksDowngradeOutperform -> Neutral$36.80ViewTweet This Rating  Share This Rating on StockTwits
7/15/2014WainwrightInitiated CoverageBuy$40.00ViewTweet This Rating  Share This Rating on StockTwits
7/15/2014HC WainrightInitiated CoverageBuy$40.00ViewTweet This Rating  Share This Rating on StockTwits
11/15/2013Citigroup Inc.Reiterated RatingBuy$42.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
6/26/2013WedbushInitiated CoverageOutperform$37.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2013JMP SecuritiesInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
6/25/2013Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
6/25/2013Leerink SwannInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
6/25/2013Citigroup Inc.Initiated CoverageBuy$32.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/27/2012 forward)